• Flora Growth business divisions include pharmaceuticals, cosmetics, hemp textiles, and food & beverage sectors
• Flora Lab now has three GMP certifications – one each for cosmetics, phytotherapeutic products, and dietary supplements
• Flora Growth operates internationally but has its cultivation and processing operations based in Colombia – with one of the largest outdoor cultivation facilities in the world, aiming to produce medical-grade cannabis flower and derivative products at below-market pricing
• Proposed acquisitions of Vessel Brand and Koch & Gsell, as well as investment into Hoshi International, will help expand the business across international borders and into the US, Europe, and Asia

An internationally focused cannabis CPG company that leverages natural and cost-effective cultivation practices to supply cannabis flower and derivatives to its diverse business divisions, Flora Growth (NASDAQ: FLGC) operates in the pharmaceutical, cosmetics, hemp textiles, and food & beverage sectors. By focusing and prioritizing natural ingredients and sustainability across the value chain of its entire business portfolio, the company is making mindful, premium products to help consumers restore and thrive around the globe. 

Additionally, Flora Growth operates one of the largest outdoor cultivation facilities in the world, where it produces medical-grade cannabis flower and derivative products at below-market pricing. After completing the first traditional cannabis IPO on NASDAQ without a SPAC, reverse merger, or a dual listing in May 2021, the company is currently seeking revenue-generating acquisitions and strategic partnerships that offer a larger distribution network, amplify revenue growth, and complement its human capital. Each brand in its current portfolio is in line with the company’s mission to be innovative while prioritizing natural ingredients and value-chain sustainability.

• Flora Lab S.A.S – Flora Lab is a GMP-certified manufacturing and R&D center focused on producing pharmaceuticals, cosmetics, and nutraceuticals for domestic and international markets. Thanks to Flora Lab, Flora Growth has a relationship with 2,500+ distribution channels, manufactures 63+ OTC products registered with INVIMA (Colombia National Food and Drug Surveillance Institute), and holds three GMP certificates.
• Flora Beauty – Flora Beauty is Flora Growth’s CBD beauty and cosmetics division founded by fashion and beauty industry icon Paulina Vega. There are currently two CBD-focused skincare brands targeting the United States and the Latin American market – MIND NATURALS and Ô (“AWE”). These products are currently offered globally through e-commerce and the 111 Falabella’s stores located throughout Latin America.
• KASA Wholefoods – KASA Wholefoods is a Colombian manufacturer of food and beverages leveraging responsibly sourced exotic fruits from Amazon. KASA has a distribution agreement anticipated to be worth over $10 million with Tropi, Colombia’s largest food distributor.
• Hemp Textiles & Co. – Through the hemp textiles division, Flora Growth intends to utilize its cultivation and processing infrastructure to capture market share in the rapidly growing hemp industrial segment. Its first brand, Stardog Loungewear, is a line of comfortable loungewear made from natural, organic materials.

In recent months, Flora has announced three major transactions – Vessel Brand, Koch & Gsell, and Hoshi International. The acquisition of Vessel Brand is expected to expand Flora’s premium brand and product portfolio by adding an industry leader in luxury cannabis consumer technology hardware and accessories, while also further diversifying Flora’s global distribution channels, and adding key human capital. Koch & Gsell provides a distribution network of 2,500+ stores to introduce Flora Growth’s products to the Swiss, European, and Asian markets. The acquisition promises to bring patented hemp cigarette manufacturing technology into new markets using Flora Growth’s quality cannabis. The investment into Hoshi International opens a gateway for Flora Growth’s cannabis products through international distribution agreements in the EU and the UK. Hoshi’s experienced team and increased access to the EU cannabis market serve as a catalyst for revenue growth.

In a recent news release, Flora Growth announced that its Flora Lab division has received authorization from the Colombian National Food and Drug Surveillance Institute (FDA equivalent) to be a Good Manufacturing Practices (“GMP”) certified manufacturer for cosmetic products (https://ibn.fm/0IHUz). The company now has three GMP certifications – for cosmetics, phytotherapeutics, and dietary supplements.

For more information, visit the company’s website at www.FloraGrowth.ca.

NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://ibn.fm/FLGC

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.